368 related articles for article (PubMed ID: 36958173)
1. Molecular docking of monkeypox (mpox) virus proteinase with FDA approved lead molecules.
Arasu MV; Vijayaragavan P; Purushothaman S; Rathi MA; Al-Dhabi NA; Gopalakrishnan VK; Choi KC; Ilavenil S
J Infect Public Health; 2023 May; 16(5):784-791. PubMed ID: 36958173
[TBL] [Abstract][Full Text] [Related]
2. Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus.
Ajmal A; Mahmood A; Hayat C; Hakami MA; Alotaibi BS; Umair M; Abdalla AN; Li P; He P; Wadood A; Hu J
Front Cell Infect Microbiol; 2023; 13():1159389. PubMed ID: 37313340
[TBL] [Abstract][Full Text] [Related]
3. Human monkeypox virus in the shadow of the COVID-19 pandemic.
Khamees A; Awadi S; Al-Shami K; Alkhoun HA; Al-Eitan SF; Alsheikh AM; Saeed A; Al-Zoubi RM; Zoubi MSA
J Infect Public Health; 2023 Aug; 16(8):1149-1157. PubMed ID: 37269693
[TBL] [Abstract][Full Text] [Related]
4. Screening of potential inhibitors against structural proteins from Monkeypox and related viruses of
Kaur M; Sharma A; Kaur H; Singh M; Devi B; Naresh Raj AR; Sood V; Pandey A; Gartia J; Kumar R; Suresh Babu AR; Singh G; Barnwal RP
J Biomol Struct Dyn; 2023 Sep; ():1-16. PubMed ID: 37776002
[TBL] [Abstract][Full Text] [Related]
5. Exploration of Microbially Derived Natural Compounds against Monkeypox Virus as Viral Core Cysteine Proteinase Inhibitors.
Dubey A; Alawi MM; Alandijany TA; Alsaady IM; Altwaim SA; Sahoo AK; Dwivedi VD; Azhar EI
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680291
[TBL] [Abstract][Full Text] [Related]
6. Drug repurposing for Mpox: Discovery of small molecules as potential inhibitors against DNA-dependent RNA polymerase using molecular modeling approach.
Dutt M; Kumar A; Rout M; Dehury B; Martinez G; Ndishimye P; Kelvin AA; Kelvin DJ
J Cell Biochem; 2023 May; 124(5):701-715. PubMed ID: 36946432
[TBL] [Abstract][Full Text] [Related]
7. In silico identification of potential inhibitors of vital monkeypox virus proteins from FDA approved drugs.
Sahoo AK; Augusthian PD; Muralitharan I; Vivek-Ananth RP; Kumar K; Kumar G; Ranganathan G; Samal A
Mol Divers; 2023 Oct; 27(5):2169-2184. PubMed ID: 36331784
[TBL] [Abstract][Full Text] [Related]
8. Structure of monkeypox virus poxin: implications for drug design.
Duchoslav V; Boura E
Arch Virol; 2023 Jun; 168(7):192. PubMed ID: 37378908
[TBL] [Abstract][Full Text] [Related]
9. In-silico targeting TMPK from monkey pox virus: Molecular docking analysis, density functional theory studies and molecular dynamic simulation analysis.
Sib Tul Hassan Shah S; Naeem I
J Biomol Struct Dyn; 2023; 41(24):14689-14701. PubMed ID: 36970852
[TBL] [Abstract][Full Text] [Related]
10. Mpox virus Clade IIb detection in the air.
Saied AA
J Med Virol; 2023 May; 95(5):e28775. PubMed ID: 37212310
[TBL] [Abstract][Full Text] [Related]
11. Identifying potential monkeypox virus inhibitors: an
Ashley CN; Broni E; Wood CM; Okuneye T; Ojukwu MT; Dong Q; Gallagher C; Miller WA
Front Cell Infect Microbiol; 2024; 14():1351737. PubMed ID: 38500508
[TBL] [Abstract][Full Text] [Related]
12. Identification of core therapeutic targets for Monkeypox virus and repurposing potential of drugs against them: An in silico approach.
Sahu A; Gaur M; Mahanandia NC; Subudhi E; Swain RP; Subudhi BB
Comput Biol Med; 2023 Jul; 161():106971. PubMed ID: 37211001
[TBL] [Abstract][Full Text] [Related]
13. Knowledge and attitudes of health care workers about monkeypox virus infection in Southern Italy.
Miraglia Del Giudice G; Della Polla G; Folcarelli L; Napoli A; Angelillo IF;
Front Public Health; 2023; 11():1091267. PubMed ID: 36923038
[TBL] [Abstract][Full Text] [Related]
14. Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023.
Rao AK; Schrodt CA; Minhaj FS; Waltenburg MA; Cash-Goldwasser S; Yu Y; Petersen BW; Hutson C; Damon IK
MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(9):232-243. PubMed ID: 36862595
[TBL] [Abstract][Full Text] [Related]
15. Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study.
Preet G; Oluwabusola ET; Milne BF; Ebel R; Jaspars M
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430762
[TBL] [Abstract][Full Text] [Related]
16. Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis.
Karagoz A; Tombuloglu H; Alsaeed M; Tombuloglu G; AlRubaish AA; Mahmoud A; Smajlović S; Ćordić S; Rabaan AA; Alsuhaimi E
J Infect Public Health; 2023 Apr; 16(4):531-541. PubMed ID: 36801633
[TBL] [Abstract][Full Text] [Related]
17. Mpox Virus: Its Molecular Evolution and Potential Impact on Viral Epidemiology.
Yu X; Shi H; Cheng G
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112975
[TBL] [Abstract][Full Text] [Related]
18. Monkeypox outbreak in the post-eradication era of smallpox.
Kandra NV; Varghese AM; Uppala PK; Uttaravelli U; Lavanya B; Shabana SKM; Somarouthu VS; Balijepalli MK
Egypt J Intern Med; 2023; 35(1):10. PubMed ID: 36777901
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis and mapping of Viral-Host Protein interactions of Poxviridae suggests a lead candidate molecule targeting Mpox.
Loganathan T; Fletcher J; Abraham P; Kannangai R; Chakraborty C; El Allali A; Alsamman AM; Zayed H; C GPD
BMC Infect Dis; 2024 May; 24(1):483. PubMed ID: 38730352
[TBL] [Abstract][Full Text] [Related]
20. Possible role of CNS microRNAs in Human Mpox virus encephalitis-a mini-review.
Soltani S; Shahbahrami R; Jahanabadi S; Siri G; Emadi MS; Zandi M
J Neurovirol; 2023 Apr; 29(2):135-140. PubMed ID: 36964438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
